tiprankstipranks
PYC Therapeutics Limited (AU:PYC)
ASX:PYC
Australian Market

PYC Therapeutics Limited (PYC) Financial Statements

Compare
27 Followers

PYC Therapeutics Limited Financial Overview

PYC Therapeutics Limited's market cap is currently AU$746.57M. The company's EPS TTM is AU$-0.094; its P/E ratio is ―; PYC Therapeutics Limited is scheduled to report earnings on February 27, 2025, and the estimated EPS forecast is AU$-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 22.06MAU$ 15.81MAU$ 16.04MAU$ 3.07MAU$ 2.40M
Gross ProfitAU$ 22.06MAU$ 14.92MAU$ 15.20MAU$ 2.45MAU$ 1.85M
Operating IncomeAU$ -38.86MAU$ -39.16MAU$ -30.21MAU$ -21.83MAU$ -9.70M
EBITDAAU$ -38.12MAU$ -38.25MAU$ -29.39MAU$ -21.04MAU$ -8.89M
Net IncomeAU$ -37.73MAU$ -22.79MAU$ -13.86MAU$ -17.77MAU$ -6.82M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 66.87MAU$ 15.57MAU$ 29.11MAU$ 51.50MAU$ 25.43M
Total AssetsAU$ 91.24MAU$ 37.17MAU$ 45.35MAU$ 57.94MAU$ 31.55M
Total DebtAU$ 1.11MAU$ 315.49KAU$ 943.77KAU$ 730.35KAU$ 798.14K
Net DebtAU$ -65.76MAU$ -15.26MAU$ -28.17MAU$ -17.70MAU$ -6.44M
Total LiabilitiesAU$ 10.18MAU$ 8.72MAU$ 5.15MAU$ 4.02MAU$ 1.35M
Stockholders' EquityAU$ 80.50MAU$ 27.75MAU$ 39.35MAU$ 53.04MAU$ 28.45M
Cash Flow
Free Cash FlowAU$ -38.90MAU$ -24.91MAU$ -22.17MAU$ -12.38MAU$ -5.85M
Operating Cash FlowAU$ -38.59MAU$ -24.42MAU$ -21.78MAU$ -11.79MAU$ -5.75M
Investing Cash FlowAU$ -307.04KAU$ -477.12KAU$ 32.68MAU$ -15.52MAU$ -13.77M
Financing Cash FlowAU$ 90.19MAU$ 11.44MAU$ -182.36KAU$ 38.56MAU$ 25.11M
Currency in AUD

PYC Therapeutics Limited Earnings and Revenue History

PYC Therapeutics Limited Debt to Assets

PYC Therapeutics Limited Cash Flow

PYC Therapeutics Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis